Basil S. Lewis
Brigham and Women's Hospital
3 papers in the Anchorcite directory, published between 2009 and 2015, cited 24,966 times in total.
ORCID profileResearch topics
- Acute Ischemic Stroke Management · 2 papers
- Atrial Fibrillation Management and Outcomes · 2 papers
- Venous Thromboembolism Diagnosis and Management · 2 papers
- Lipoproteins and Cardiovascular Health · 1 paper
- Cholesterol and Lipid Metabolism · 1 paper
- Acute Myocardial Infarction Research · 1 paper
Frequent co-authors
- Jun Zhu · 2 papers
- Rafael Díaz · 2 papers
- Harald Darius · 2 papers
- Lars C. Wallentin · 2 papers
- Stuart J. Connolly · 1 paper
- Michael D. Ezekowitz · 1 paper
- Salim Yusuf · 1 paper
- John W. Eikelboom · 1 paper
Papers
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine · 2009 · 11,314 citations
BACKGROUND: Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases the risk of hemorrhage and is difficult to use. Dabigatran is a new oral direct thrombin inhibitor. METHODS: In this noninferiority trial, we randomly assigned 18,113…
- Apixaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine · 2011 · 9,052 citations
BACKGROUND: Vitamin K antagonists are highly effective in preventing stroke in patients with atrial fibrillation but have several limitations. Apixaban is a novel oral direct factor Xa inhibitor that has been shown to reduce the risk of stroke in a…
- Ezetimibe Added to Statin Therapy after Acute Coronary SyndromesNew England Journal of Medicine · 2015 · 4,600 citations
BACKGROUND: Statin therapy reduces low-density lipoprotein (LDL) cholesterol levels and the risk of cardiovascular events, but whether the addition of ezetimibe, a nonstatin drug that reduces intestinal cholesterol absorption, can reduce the rate of cardiovascular events further is not known.…
Metadata from OpenAlex (CC0).